South & Central America Microcarriers Market

The South & Central America microcarriers market is expected to grow from US$ 68.77 million in 2022 to US$ 129.96 million by 2030. It is estimated to register a CAGR of 8.3% from 2022 to 2030.

Automation of Cell and Gene Therapy Manufacturing Services Drives South & Central America Microcarriers Market

Incorporating automation in cell and gene therapy manufacturing would lead to a reduced risk of contamination, improved consistency, and decreased cost of production. Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are a few of the devices available in the market that have been designed to enable the automation of most sequential unit operations for a CAR-T process within a single system. The rising demand for cell and gene therapies has shifted production from a small-volume process to a large-volume process worldwide. The progress of cell and gene therapy from an academic and clinical setting to mass production and commercialization further propels the demand for automation in commercial manufacturing. Thus, automation is emerging as a new trend in the microcarriers market.

South & Central America Microcarriers Market Overview

The South & Central America microcarriers market is segmented into Brazil, Argentina, and the Rest of South & Central America. A surge in various research activities, rising healthcare expenditure, growing investments in biotechnology, burgeoning incidences of infectious diseases, and government efforts to promote the utilization of immobilized cell culture media to ease the healthcare processes are major factors contributing to the growth of the market. According to a report titled "First Gene Therapy Products Approved in Brazil," published by Law Business Research 2020, Brazil is among the first Latin American countries to approve the marketing of gene therapy products. The Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization for Novartis' gene therapy products-Luxturna and Zolgensma. Both products were approved by the Brazilian Technical Commission of Biosafety (CTNBio), which is responsible for evaluating the biosafety of genetically modified organisms in Brazil. In September 2021, Sorrento Therapeutics began subject enrolment in the Phase II clinical trial of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC) for treating COVID-19 patients with acute respiratory distress syndrome (ARDS) or acute respiratory distress (ARD) in Brazil. Thus, such advancements in cell therapy boost the growth of the microcarriers market in Brazil.

South & Central America Microcarriers Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Microcarriers Market Segmentation

The South & Central America microcarriers market is segmented into product, equipment, application, end user, and country.

Based on product, the South & Central America microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the South & Central America microcarriers market in 2022.

In terms of equipment, the South & Central America microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the South & Central America microcarriers market in 2022.

Based on application, the South & Central America microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the South & Central America microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.

Based on end user, the North America microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the North America microcarriers market in 2022.

Based on country, the South & Central America microcarriers market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America microcarriers market in 2022.

Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the South & Central America microcarriers market.

South & Central America Microcarriers Strategic Insights

Strategic insights for the South & Central America Microcarriers provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

South & Central America Microcarriers Report Scope

South & Central America Microcarriers Regional Insights

The geographic scope of the South & Central America Microcarriers refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.